Skip to main content
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
6.06
+0.01 (0.17%)
Nov 4, 2024, 4:00 PM EST - Market closed

Outlook Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
24
Market Cap
143.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023---
Sep 30, 2022---
Sep 30, 2021---
Sep 30, 2020---
Sep 30, 20198.15M5.06M163.84%
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro
Sep 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MultiPlan 954.92M
Puma Biotechnology 219.14M
InfuSystem Holdings 129.37M
Aclaris Therapeutics 32.02M
Generation Bio Co. 13.17M
Cardiff Oncology 665.00K
Inovio Pharmaceuticals 591.86K
Seres Therapeutics 374.00K
Revenue Rankings

OTLK News

More News